Author Question: The Oucher pain assessment tool is for use with children of ages: a. 1 to 2 years c. 12 to 14 ... (Read 41 times)

Chloeellawright · **on:** Jun 27, 2018

The Oucher pain assessment tool is for use with children of ages:

a. 1 to 2 years c. 12 to 14 years
b. 3 to 12 years d. 15 to 18 years

Question 2

A nurse is reviewing the immunization schedule for a 9-month-old infant. The schedule notes that the child is due to receive the Rotarix vaccine today.

During the assessment, the mother tells the nurse that the child had surgery three weeks ago for intussusception. The nurse knows that: 1. The child should wait to get the vaccine because of the recent surgery.
2. The child should not receive the vaccine because of the past history of intussusception.
3. The child should be positioned so that the medication can be given orally.
4. The child should receive the medication regardless of past history.

ong527 · **Reply #1 on:** Jun 27, 2018

Answer to Question 1

B

Feedback
A Incorrect: The Oucher pain assessment tool is not for use with children of ages 1 to 2 years, as it is numeric and uses photos of children in pain.
B Correct: The Oucher pain assessment tool is for use with children of ages 3 to 12 years. The Oucher pediatric pain intensity scale consists of two scales: a 0 to 100 numeric scale and a 6-point facial scale. If the child can count, the numeric scale can be used. The facial scale can be successfully used in children as young as 3 to 4 years.
C Incorrect: The Oucher pain assessment tool is not for use with children above the age of 12, the Adolescent and Pediatric Pain Tool (APPT) is more appropriate.
D Incorrect: The Oucher pain assessment tool is not for use with children above the age of 12, the Adolescent and Pediatric Pain Tool (APPT) is more appropriate.

Answer to Question 2

2
Feedback
1. The timing of the vaccine is not the priority.
2. A child with a GI issue should not receive Rotarix.
3. Does not come in oral form
4. Past history influences if the child can have the vaccine.